Navigation Links
Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain
Date:6/30/2009

ccine business is currently a key part of the strategy of ROVI, and we are committed to the business as one of the future growth drivers for the company. We are entering a new world of high technology and complex processes, but we are confident that our knowledge in this area along with Novavax's extensive experience will enable us to fight on the front line against the devastating effects of influenza virus infection."

ABOUT ROVI

ROVI is a fully integrated, profitable Spanish specialty pharmaceutical company engaged in the research, development, in-licensing, manufacturing and marketing of small molecule and specialty biologic drugs. The Company has a diversified portfolio of products that it markets in Spain through its specialized sales force, calling on specialist physicians, hospitals and pharmacies. ROVI's portfolio of 23 principal marketed products is currently anchored by the internally-developed, second generation low molecular weight heparin, bemiparin. ROVI's research and development pipeline is focused primarily on addressing currently unmet medical needs by developing new LMWH-based products and expanding applications for its existing LMWH-based products. ROVI manufactures the active biological ingredient (bemiparin) for its principal proprietary product and product candidates and the injectable pharmaceutical products developed by its in-house research team, and utilizes its state-of-the-art filling and packaging capabilities to provide a broad array of toll manufacturing services to leading international pharmaceutical companies, primarily in the area of pre-filled syringes.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company creating novel vaccines, including H1N1, to address a broad range of infectious diseases worldwide using advanced proprietary virus-lik
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. LMXonline Offers Spanish-Language Safety and Health Training Library
2. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
3. Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
4. Sundias Animal Facility Passed Client and Government Inspection
5. PTC Therapeutics Receives $2.6 Million in Government Grants
6. Neogen Partners With Chinese Government
7. GeneNews to conduct joint project funded by MYR 5 million grant from Malaysian government
8. Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006
9. Canadian Government Announces Funding for Leading Biotechnology Firms Project
10. Mental Stimulus Package: Government Officials who Forgot to Pay Taxes Will Receive Free Memory-boosting Supplement
11. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ire/ -- The endangered black-footed ferrets inhabi... carnivore feeds on prairie dogs. The prairie do... population die-offs in towns occur. The U.S. Fis...erret breeding program and has been releasing trai...bitat. Unfortunately, plague can sweep through an...
(Date:11/5/2009)...Newswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq...ts for processing and storing adult stem cells, to...al 2010. ,, For the quarter ended September 30,...on, a 15 percent increase over revenues of $4.5 mi... said the key contributors to the growth in revenu...
(Date:11/5/2009)...-FirstCall/ -- BioSpecifics Technologies Corp. (Na...ing first-in-class collagenase-based products, tod...uarter ended September 30, 2009. ,, "We were e...e FDA,s Arthritis Advisory Committee unanimously r...FLEX(TM) for the treatment of Dupuytren,s disease,...
(Date:11/5/2009)...RNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SN... receptor-based technologies to discover novel fla...ient supply industries, today provided a corporate...rd quarter ended September 30, 2009. Revenues wer...ared to $4.0 million for the third quarter of 2008...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
... GeneGo, Inc., the leading systems biology tools ...h of the University of Glasgow will join the Met...the program is to develop a series of blueprint pa...s, Hematopoietic, Mesenchymal, Multipotent, Neopla..."We feel that it is important to support such an i...
...2S Inc., a global provider of image management ser...nical trials, announced today that the company wil...e-of-the-art image management can enhance DXA (Dua...ervices for bone mineral density trials and issues...urements with DXA. , (PRW...
... Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) a...onal,Staff Determination letter (the "Determinatio...the "Staff") of The NASDAQ Stock Market indicating...Rule 4350(i)(1)(C) when the,Company amended the ac...SMI"),and issued additional common shares to SMI s...
Other Biology Technology:University of Glasgow Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership Program 2Free DXA Bone Mineral Density and Body Composition in Clinical Trials Webinars to be Held by M2S DXA Division Expert 2Cell Therapeutics Receives Additional NASDAQ Notification 2Cell Therapeutics Receives Additional NASDAQ Notification 3Cell Therapeutics Receives Additional NASDAQ Notification 4
(Date:11/4/2009)...SON, N.J., Oct. 20 Quest...,s leading provider of diagnostic testing, informa...arter ended September 30, 2009, income from contin... diluted share, from $160 million, or $0.81 per di...8, third quarter results were reduced by a $0.03 p...
(Date:11/4/2009)...E, N.Y., Oct. 21 What,s the cost o...ng accidental death resulting from prescription me... good intentions, however, may be unaware that the...heir teens from the ticking timebomb of prescripti... in premium-quality medical supplies, has formed a...
(Date:11/4/2009)...YORK, Oct. 27 Global Rainmakers, I...advanced R&D laboratory, today announced that ...repared to actively commercialize its suite of tec...ric security offerings. ,, During the past four...dollars to develop and deploy a series of core--bu...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi aventis in the U S 13374 1The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi aventis in the U S 13374 2The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi aventis in the U S 13374 3The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi aventis in the U S 13374 4NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 1NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 2NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 3NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 4ReGen Biologics Clarifies Recent Press about the Menaflex Device 53699 1ReGen Biologics Clarifies Recent Press about the Menaflex Device 53699 2
...pths of the South Pacific Ocean harbor toxins that..., according to research findings from University o...colleagues. , The research team has defined the st...anding that can be used to synthesize pharmaceutic...he Proceedings of the National Academy of Sciences...
...at was found be an ozone depletor are now being ev...a, say plant pathologists with USDA,s Agricultural...ontreal Protocol called for the phase-out of methy...ne fungi, nematodes, and weeds of more than 100 cr...romide,s ability to deplete ozone and disrupt the ...
...ase, destroying invading microbes with a swarm of ... apparent reason, ganging up on normal tissues in ...ple each year, the immune system attacks the inner...llow us to hear. Without warning, in days or weeks... ears. Some might get part or all of their hearing...
Other Biology News:Structures of marine toxins provide insight into their effectiveness as cancer drugs 2Plant pathologists evaluate eco-friendly alternatives to methyl bromide 2New Lab Research May Help Those Deafened By Immune System Attack 2New Lab Research May Help Those Deafened By Immune System Attack 3New Lab Research May Help Those Deafened By Immune System Attack 4
... Mixes are formulated for use in one-step QRT-PCR ...en. One-step QRT-PCR mixes offer a quick and simpl...e minimised, making the protocol easy to follow an...x is supplied with a patented blend of RTases comb...
SphingoBeads from Echelon Biosciences Inc.
...thetic Peptide: M(1) E F L P E P Q H P P G P P T M...tein 3 (Mint3) from mouse cells.,PA1-072 has ... By Western blot, this antibody detects an ~86 kD...ct.,PA1-072 immunizing peptide corresponds to...
Rabbit Anti-Staphylococcus Enterotoxin A Polyclonal Antibody, Horseradish Peroxidase Conjugated from Abcam
Biology Products: